Rethinking Ameloblastic Fibroma and Fibro-odontoma: A Serie of 6 Cases and Reclassification Proposal
- PMID: 40560304
- PMCID: PMC12198082
- DOI: 10.1007/s12105-025-01818-7
Rethinking Ameloblastic Fibroma and Fibro-odontoma: A Serie of 6 Cases and Reclassification Proposal
Abstract
Purpose: The classification of mixed odontogenic tumors-specifically ameloblastic fibroma (AF), ameloblastic fibro-odontoma (AFO), and odontoma-remains controversial. The current WHO classification emphasizes the presence of dental hard tissues but overlooks the distinction between aberrant inductive activity and maturation resembling normal odontogenesis. This has led to diagnostic ambiguity and inconsistent management strategies. This study aims to propose a biologically grounded reclassification based on histological, developmental, and molecular criteria.
Methods: We conducted a conceptual reassessment of AF, AFO, and odontoma, using six cases from our pathology archives. Histological slides were reviewed with focus on the type and organization of mineralized tissue (tubular dentin, osteodentine, enamel) and its epithelial-mesenchymal context. Clinical and radiological data were evaluated, and BRAF V600E mutation status was retrieved when available. A targeted literature review was performed to integrate findings on histology, genetic alterations, and malignant transformation risk.
Results: Two distinct lesion types were identified: (1) Ameloblastic fibroma with aberrant inductive activity, showing irregular osteodentine and enameloid deposits without odontoblast differentiation, harboring BRAF mutations; and (2) odontomas, characterized by mature tubular dentin and enamel formation, indicating a hamartomatous nature, despite significant clinical growth. Historical descriptions support this biological dichotomy, emphasizing the difference between aberrant inductive activity and processes resembling normal odontogenesis.
Conclusion: We propose abandoning AFO as a distinct diagnostic entity. Instead, lesions could be classified based on the presence of organized, mature dental hard tissues. AF with aberrant inductive activity represents a benign neoplasm with low malignant potential, while odontoma is a hamartomatous lesion sometimes with large growth capacity but no malignant risk. This binary classification would align histological criteria with biological behavior, integrate molecular data, and restore diagnostic clarity. The validity of this framework should be investigated in future cohorts.
Keywords: Ameloblastic fibro-odontoma; Ameloblastic fibroma; BRAF mutations; Epithelial-mesenchymal interaction; Odontogenic tumors; Odontoma.
© 2025. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of interest: The authors declare that they have no conflict of interest. Ethical Approval: Cases were collected under IRB approval S65708. Consent for Publication: For this type of study consent for publication is not required. Informed Consent: For this type of study formal consent is not required.
Similar articles
-
New Insights into Ameloblastic Fibromas, Fibrodentinomas, and Fibro-Odontomas: Findings from an International Multicenter Study.Head Neck Pathol. 2025 May 8;19(1):57. doi: 10.1007/s12105-025-01792-0. Head Neck Pathol. 2025. PMID: 40338415
-
Ameloblastic Fibro-Odontoma with an FGFR1 Mutation: A Case Report.Head Neck Pathol. 2025 Feb 5;19(1):19. doi: 10.1007/s12105-025-01758-2. Head Neck Pathol. 2025. PMID: 39907837 Free PMC article.
-
Ameloblastic fibroma and related lesions: current pathologic concept.Oral Oncol. 1999 Nov;35(6):535-40. doi: 10.1016/s1368-8375(99)00039-1. Oral Oncol. 1999. PMID: 10705086 Review.
-
Are Ameloblastic Fibroma-related Lesions True Tumors?: Evidence Through CNA and BRAF Mutation Analysis.Am J Surg Pathol. 2024 Dec 1;48(12):1481-1490. doi: 10.1097/PAS.0000000000002319. Epub 2024 Oct 11. Am J Surg Pathol. 2024. PMID: 39450987
-
Ameloblastic Fibrodentinoma and Ameloblastic Fibro-Odontoma: An Updated Systematic Review of Cases Reported in the Literature.J Oral Maxillofac Surg. 2017 Jul;75(7):1425-1437. doi: 10.1016/j.joms.2016.12.038. Epub 2017 Jan 6. J Oral Maxillofac Surg. 2017. PMID: 28153756
References
-
- Barnes L, Eveson J, Reichart P, Sidransky D (2005) Pathology & genetics of head and neck tumours. International Agency for Research on Cancer, Lyon
-
- Buchner A, Vered M (2013) Ameloblastic fibroma: a stage in the development of a hamartomatous odontoma or a true neoplasm? Critical analysis of 162 previously reported cases plus 10 new cases. Oral Surg Oral Med Oral Pathol Oral Radiol 116:598–606. 10.1016/J.OOOO.2013.06.039 - PubMed
-
- Chen Y, Wang JM, Li TJ (2007) Ameloblastic fibroma: a review of published studies with special reference to its nature and biological behavior. Oral Oncol 43:960–969. 10.1016/J.ORALONCOLOGY.2007.05.009 - PubMed
-
- El-Naggar AK, Chan JKC, Grandis JR et al (2017) WHO classification of head and neck tumours, 4th edn. International Agency for Research on Cancer, Lyon
-
- Gorlin RJ, Chaudhry AP, Pindborg JJ (1961) Odontogenic tumors. Classification, histopathology, and clinical behavior in man and domesticated animals. Cancer 14:73–101 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials